ENOV
Enovis Corporation
NYSEUSDEQUITY
Healthcare
DELAYED
Sell
-24/100
Last price
18.20
▼ 0.49 (2.62%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
18.70
Prev close
18.69
Day high
19.00
Day low
18.06
Volume
1.02M
Market cap
$1.05B
P/E (TTM)
—
52W range
17.30 – 34.28
Day trading desk
Gap from prior close
+0.05%
Prior close 18.69
VWAP
18.25
-0.30% from price
Relative volume
1.39×
Normal
Session range
5.29%
18.06 – 19.01
Position in range
15%
Near session low
ATR (14D)
0.81
4.44% of price
Prior day high
18.96
PDH
Prior day low
17.56
PDL
Bid / ask spread
—
Quote not published
Session volume
2.01M
Avg 1.44M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-1.41%
-3.4%
1M
-1.94%
-3.1%
3M
-22.98%
-27.5%
6M
-19.18%
-37.4%
YTD
-31.68%
-45.9%
1Y
-43.16%
-59.6%
3Y
-65.48%
-147.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on ENOV open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
946.93K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 4, 26 | ENGERT OLIVER Officer |
BUY | 2.66K | $50.01K | Direct |
| Sep 4, 26 | MCDONALD DAMIEN Chief Executive Officer |
BUY | 13.04K | $249.62K | Direct |
| Sep 3, 26 | ENGERT OLIVER Officer |
BUY | 7.60K | $149.97K | Direct |
| Jun 30, 26 | ORTIZ CHRISTINE Director |
STOCK | 846 | $0 | Direct |
| Jun 15, 26 | ENGERT OLIVER Officer |
BUY | 1.00K | $20.92K | Direct |
| Jun 11, 26 | ENGERT OLIVER Officer |
BUY | 1.20K | $25.95K | Direct |
| Jun 11, 26 | ENGERT OLIVER Officer |
STOCK | 1.20K | $25.19K | Direct |
| Jun 10, 26 | ENGERT OLIVER Officer |
BUY | 1.00K | $23.00K | Direct |
| Jun 1, 26 | ENGERT OLIVER Officer |
BUY | 1.00K | $22.22K | Direct |
| May 19, 26 | VINNAKOTA RAJIV Director |
STOCK | 9.35K | $0 | Direct |
| May 19, 26 | KELLY LIAM J Director |
STOCK | 9.35K | $0 | Direct |
| May 19, 26 | LALOR ANGELA S Director |
STOCK | 9.35K | $0 | Direct |
| May 19, 26 | PERFALL A CLAYTON Director |
STOCK | 9.35K | $0 | Direct |
| May 19, 26 | WIENBAR SHARON L Director |
STOCK | 9.35K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BERRY PHILLIP BENJAMIN BEN |
Chief Financial Officer | 158.60K | Stock Award(Grant) |
ENGERT OLIVER |
Officer | 63.90K | Purchase |
LANG PATRICIA A |
Officer | 75.70K | Stock Award(Grant) |
MCDONALD DAMIEN |
Chief Executive Officer | 247.08K | Purchase |
PRYOR DANIEL ALEXIS |
Former | — | Sale |
ROSS TERRY D |
Officer | 68.48K | Stock Award(Grant) |
SHIRLEY BRADY R. |
Director | 110.59K | Stock Award(Grant) |
TANDY BRADLEY J |
Officer | 65.64K | Stock Award(Grant) |
TREROTOLA MATTHEW L. |
Chief Executive Officer | 373.51K | Stock Award(Grant) |
VOGT LOUIS |
Officer | 68.88K | Stock Award(Grant) |
Fundamentals
Market cap$1.05B
Enterprise value$2.41B
Revenue (TTM)$2.30B
Gross profit$1.41B
EBITDA$379.78M
Net income$-1.10B
EPS (TTM)$-18.73
Free cash flow$185.94M
Total cash$12.56M
Total debt$1.37B
Book value / share$25.62
Shares outstanding57.67M
Float52.76M
Short % of float19.60%
Dividend yield0.00%
Beta (5Y)1.48
Valuation & profitability ratios
Trailing P/E—
Forward P/E5.07
PEG ratio3.45
Price / sales—
Price / book0.71
EV / revenue1.05
EV / EBITDA6.34
Gross margin61.32%
Operating margin4.18%
Profit margin-47.97%
Return on equity-54.14%
Return on assets1.20%
Debt / equity92.56
Current ratio1.99
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $2.25B | $2.11B | $1.71B | $1.56B | +6.7% |
| Operating revenue | $2.25B | $2.11B | $1.71B | $1.56B | +6.7% |
| Cost of revenue | $902.79M | $926.87M | $716.42M | $693.72M | -2.6% |
| Gross profit | $1.35B | $1.18B | $990.78M | $869.38M | +13.9% |
| Research & development | $120.33M | $91.30M | $75.33M | $60.83M | +31.8% |
| Selling, general & admin | $1.07B | $1.03B | $830.30M | $772.91M | +4.2% |
| Total operating expense | $1.36B | $1.28B | $1.04B | $960.04M | +6.2% |
| Operating income | -$18.87M | -$103.43M | -$48.37M | -$90.66M | +81.8% |
| Net interest income | -$34.82M | -$57.10M | -$19.75M | -$24.05M | +39.0% |
| Pre-tax income | -$1.16B | -$822.92M | -$67.13M | -$2.07M | -40.9% |
| Tax provision | $22.29M | $4.49M | -$13.29M | $36.12M | +396.3% |
| Net income | -$1.18B | -$825.49M | -$33.26M | -$13.29M | -43.5% |
| Net income to common | -$1.18B | -$825.49M | -$33.26M | -$13.29M | -43.5% |
| Basic EPS | -20.75 | -14.93 | -0.61 | -0.25 | -39.0% |
| Diluted EPS | -20.75 | -14.93 | -0.61 | -0.25 | -39.0% |
| EBIT | -$1.12B | -$765.82M | -$47.38M | $21.98M | -46.8% |
| EBITDA | -$830.22M | -$481.03M | $169.73M | $241.69M | -72.6% |
| Basic shares | 57.08M | 55.29M | 54.53M | 53.17M | +3.2% |
| Diluted shares | 57.08M | 55.29M | 54.98M | 53.17M | +3.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $36.39M | $48.17M | $36.19M | $24.30M | — | -24.5% |
| Cash & short-term investments | $36.39M | $48.17M | $36.19M | $24.30M | — | -24.5% |
| Accounts receivable | $442.79M | $407.03M | $291.48M | $267.38M | — | +8.8% |
| Inventory | $584.38M | $547.12M | $468.83M | $426.64M | — | +6.8% |
| Total current assets | $1.21B | $1.15B | $896.52M | $795.02M | — | +5.3% |
| Property, plant & equipment | $579.32M | $473.42M | $334.30M | $303.62M | — | +22.4% |
| Goodwill & intangibles | $1.96B | $3.01B | $3.19B | $3.09B | — | -35.1% |
| Total assets | $3.83B | $4.72B | $4.51B | $4.27B | — | -18.7% |
| Total current liabilities | $598.47M | $529.00M | $369.61M | $565.20M | — | +13.1% |
| Current debt | $35.00M | $20.03M | — | $219.28M | $7.70M | +74.8% |
| Long-term debt | $1.26B | $1.31B | $466.16M | $40.00M | — | -3.6% |
| Total debt | $1.38B | $1.40B | $536.42M | $334.82M | — | -1.8% |
| Total liabilities | $2.34B | $2.15B | $1.09B | $823.45M | — | +8.7% |
| Retained earnings | -$1.47B | -$283.02M | $542.47M | $575.73M | — | -418.5% |
| Shareholder equity | $1.49B | $2.56B | $3.42B | $3.45B | — | -41.9% |
| Working capital | $608.59M | $617.45M | $526.91M | $229.82M | — | -1.4% |
| Net tangible assets | -$465.37M | -$447.88M | $230.14M | $353.77M | — | -3.9% |
| Shares issued | 57.19M | 55.88M | 54.60M | 54.23M | — | +2.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$1.18B | -$824.82M | -$32.73M | -$11.76M | -43.5% |
| Depreciation & amortisation | $294.38M | $284.80M | $217.11M | $219.71M | +3.4% |
| Stock-based compensation | $32.92M | $29.66M | $34.06M | $38.95M | +11.0% |
| Change in working capital | $15.46M | -$13.93M | -$27.27M | -$222.29M | +211.0% |
| Operating cash flow | $217.29M | $113.50M | $134.99M | -$55.86M | +91.4% |
| Capital expenditure | -$197.38M | -$180.71M | -$122.22M | -$105.45M | -9.2% |
| Investing cash flow | -$179.37M | -$955.47M | -$242.47M | -$176.39M | +81.2% |
| Financing cash flow | -$52.40M | $846.82M | $127.80M | -$465.13M | -106.2% |
| Free cash flow | $19.92M | -$67.21M | $12.77M | -$161.31M | +129.6% |
| End cash position | $36.39M | $48.17M | $44.83M | $24.30M | -24.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $582.78M | $589.15M | $575.76M | $548.91M | $564.54M | -1.1% |
| Operating revenue | $582.78M | $589.15M | $575.76M | $548.91M | $564.54M | -1.1% |
| Cost of revenue | $223.53M | $223.67M | $226.34M | $220.00M | $229.85M | -0.1% |
| Gross profit | $359.25M | $365.49M | $349.42M | $328.91M | $334.70M | -1.7% |
| Research & development | $31.69M | $31.53M | $31.36M | $29.74M | $30.70M | +0.5% |
| Selling, general & admin | $263.73M | $282.81M | $270.44M | $263.62M | $267.07M | -6.7% |
| Total operating expense | $336.98M | $356.25M | $301.17M | $337.05M | $350.78M | -5.4% |
| Operating income | $22.27M | $9.24M | $48.25M | -$8.14M | -$16.08M | +141.1% |
| Net interest income | -$8.04M | -$9.17M | -$7.51M | -$8.83M | -$9.29M | +12.3% |
| Pre-tax income | $7.46M | $634.00K | -$509.55M | -$566.87M | -$25.65M | +1,077.4% |
| Tax provision | $8.50M | $9.04M | $9.26M | $4.00M | $10.80M | -6.0% |
| Net income | -$1.19M | -$8.76M | -$520.59M | -$571.15M | -$36.74M | +86.4% |
| Net income to common | -$1.19M | -$8.76M | -$520.59M | -$571.15M | -$36.74M | +86.4% |
| Basic EPS | -0.02 | -0.15 | -9.10 | -9.99 | -0.64 | +86.7% |
| Diluted EPS | -0.02 | -0.15 | -9.10 | -9.99 | -0.64 | +86.7% |
| EBIT | $15.50M | $9.80M | -$502.03M | -$558.04M | -$16.36M | +58.1% |
| EBITDA | $86.53M | $83.16M | -$425.02M | -$483.66M | $55.19M | +4.1% |
| Basic shares | 59.50M | 58.43M | 57.21M | 57.17M | 57.40M | +1.8% |
| Diluted shares | 59.50M | 58.43M | 57.21M | 57.17M | 57.40M | +1.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $12.56M | $33.13M | $36.39M | $33.62M | $44.07M | -62.1% |
| Cash & short-term investments | $12.56M | $33.13M | $36.39M | $33.62M | $44.07M | -62.1% |
| Accounts receivable | $441.85M | $444.21M | $442.79M | $431.77M | $453.70M | -0.5% |
| Inventory | $601.66M | $602.54M | $584.38M | $613.75M | $628.22M | -0.1% |
| Total current assets | $1.21B | $1.24B | $1.21B | $1.28B | $1.28B | -2.0% |
| Property, plant & equipment | $602.37M | $594.22M | $579.32M | $559.34M | $525.31M | +1.4% |
| Goodwill & intangibles | $1.86B | $1.90B | $1.96B | $2.50B | $3.12B | -2.3% |
| Total assets | $3.77B | $3.83B | $3.83B | $4.43B | $5.02B | -1.7% |
| Total current liabilities | $612.05M | $608.66M | $598.47M | $575.44M | $568.18M | +0.6% |
| Current debt | $37.39M | $35.00M | $35.00M | $20.00M | $20.03M | +6.8% |
| Long-term debt | $1.25B | $1.29B | $1.26B | $1.34B | $1.37B | -3.4% |
| Total debt | $1.37B | $1.41B | $1.38B | $1.44B | $1.46B | -2.9% |
| Total liabilities | $2.29B | $2.35B | $2.34B | $2.41B | $2.44B | -2.8% |
| Retained earnings | -$1.48B | -$1.48B | -$1.47B | -$946.87M | -$375.73M | -0.1% |
| Shareholder equity | $1.48B | $1.48B | $1.49B | $2.02B | $2.58B | +0.0% |
| Working capital | $602.64M | $631.02M | $608.59M | $704.68M | $712.17M | -4.5% |
| Net tangible assets | -$383.11M | -$427.47M | -$465.37M | -$478.67M | -$545.13M | +10.4% |
| Shares issued | 57.67M | 57.54M | 57.19M | 57.19M | 57.16M | +0.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$1.04M | -$8.45M | -$520.45M | -$570.91M | -$36.55M | +87.7% |
| Depreciation & amortisation | $71.03M | $73.36M | $77.01M | $74.38M | $71.55M | -3.2% |
| Stock-based compensation | $8.97M | $8.75M | $8.11M | $8.73M | $8.67M | +2.5% |
| Change in working capital | -$2.00M | -$13.71M | $21.64M | $16.63M | $2.77M | +85.4% |
| Operating cash flow | $75.03M | $23.95M | $88.54M | $82.58M | $47.77M | +213.3% |
| Capital expenditure | -$43.90M | -$52.80M | -$56.25M | -$53.49M | -$44.37M | +16.9% |
| Investing cash flow | -$45.01M | -$53.09M | -$12.99M | -$56.06M | -$49.80M | +15.2% |
| Financing cash flow | -$50.56M | $26.02M | -$72.92M | -$36.91M | $6.23M | -294.3% |
| Free cash flow | $31.14M | -$28.85M | $32.29M | $29.09M | $3.40M | +207.9% |
| End cash position | $12.56M | $33.13M | $36.39M | $33.62M | $44.07M | -62.1% |
Options analytics
Put / call volume
0.09
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
30.00
+64.8% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
-6.2%
Calls bid over puts
Call volume
794
Contracts, this expiry
Put volume
68
Contracts, this expiry
Heaviest call OI
17.50
0 contracts
Heaviest put OI
30.00
4 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.85 | 0.90 | +6.3% |
| Mar 2026 | 0.81 | 0.89 | +9.9% |
| Dec 2025 | 0.84 | 0.95 | +13.1% |
| Sep 2025 | 0.65 | 0.75 | +15.6% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.77 | 13 | $557.15M | +1.5% |
| Next quarter | 1.07 | 12 | $609.48M | +5.9% |
| Current year | 3.63 | 13 | $2.34B | +4.1% |
| Next year | 3.59 | 13 | $2.45B | +4.9% |
Analyst targets & ownership
Mean target$37.58
High target$52.00
Low target$24.00
Implied upside106.50%
Analyst count12
ConsensusSTRONG BUY
Strong buy / Buy2 / 10
Hold1
Sell / Strong sell0 / 0
Held by insiders1.64%
Held by institutions124.44%
Institutions holding351
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
18.26
-0.31% from price
SMA 20
18.32
-0.65% from price
SMA 50
22.67
-19.71% from price
SMA 100
23.26
-21.76% from price
SMA 200
23.71
-23.25% from price
EMA 12
18.39
-1.04% from price
EMA 26
19.48
-6.55% from price
EMA 50
21.10
-13.76% from price
RSI (14)
40.1
Neutral
MACD (12,26,9)
-1.09
Hist 0.28
ATR (14)
0.81
4.44% of price
Realised vol 30D
69.2%
Annualised
Bollinger upper
19.06
20, 2σ
Bollinger lower
17.58
20, 2σ
50 / 200 cross
Death
22.67 vs 23.71
Trend bias
Below 200
-23.25%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.41
More volatile than market
Correlation to SPY
0.29
Largely independent
Realised vol 30D
69.2%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-45.9%
Peak to trough
Max drawdown 5Y
-80.5%
Peak to trough
ATR 14
0.81
4.44% of price
Beta (reported)
1.48
5Y monthly, from filing
Short interest
Shares short
9.48M
Prior 8.71M
Change vs prior
+8.8%
Shorts adding
% of float
19.60%
Elevated
% of shares out
16.44%
Against total outstanding
Days to cover
5.8
Crowded exit
Float
52.76M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 2, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| Sep 2, 26 | Citizens | MAINTAINED | Market Outperform | Market Outperform |
| Sep 2, 26 | Freedom Capital Markets | MAINTAINED | Buy | Buy |
| Sep 1, 26 | BTIG | MAINTAINED | Buy | Buy |
| Aug 17, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Aug 7, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| Aug 6, 26 | BTIG | MAINTAINED | Buy | Buy |
| Jul 9, 26 | BMO Capital | INITIATED | — | Outperform |
| Jul 6, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
| May 22, 26 | BTIG | MAINTAINED | Buy | Buy |
| May 8, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
| May 8, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split581:1000
Split dateApr 5, 2022
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-01
Corporate Changes & Voting Matters
8-K · 2026-08-06
Annual report of employee stock purchase
11-K · 2026-06-26
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-05-28
Offering Registrations
S-8 · 2026-05-19
Corporate Changes & Voting Matters
8-K · 2026-05-07
Proxy Statements
DEF 14A · 2026-04-06
Corporate Changes & Voting Matters
8-K · 2026-02-26
Headlines
BofA Securities Adjusts Enovis Price Target to $44 From $51, Maintains Buy Rating
MT Newswires · 2d ago
3 Small-Cap Stocks We Approach with Caution
StockStory · 2d ago
1 Oversold Stock Ready to Bounce Back and 2 That Underwhelm
StockStory · 9d ago
Sports Rehabilitation Equipment Market Global Report 2026: Capitalize on a $2.05 Billion Revenue Surge to $6.84 Billion by 2030 as AI and Robotics Disrupt Recovery—Benchmark Stryker, Smith & Nephew, Enovis, Performance Health and Life Fitness
GlobeNewswire · 9d ago
Enovis becomes first multi-registry industry sponsor of AAOS Registry Program
PR Newswire · 15d ago
2 Russell 2000 Stocks on Our Watchlist and 1 We Brush Off
StockStory · 16d ago
3 Reasons ENOV is Risky and 1 Stock to Buy Instead
StockStory · 19d ago
Insider at Medical Device Maker Buys More Than 7,500 Shares
Motley Fool · 23d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.